Kazuma Oyama

Statistics

Publications

Citations

403

H-Index

Active since

2013

Affiliations

Thrombolysis in Myocardial Infarction Study Group(Current)

Harvard University

Brigham and Women's Hospital

Tohoku University

Amgen (United States)

Kazuma Oyama is an author at Thrombolysis in Myocardial Infarction Study Group specializing in medicine, cardiovascular disease, and cardiovascular pharmacotherapy.

ORCID

Publications per year

2013–2023

Publications

Co-Existence of Carotid Artery Disease, Renal Artery Stenosis, and Lower Extremity Peripheral Arterial Disease in Patients With Coronary Artery Disease

Yoichi Imori, Takeshi Akasaka, Tomoki Ochiai et al. · The American Journal of Cardiology · 2013 · 75 citations

Medicine, Cardiology, Surgery +15

Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial

Kazuma Oyama, Itamar Raz, Avivit Cahn et al. · European Heart Journal · 2021 · 71 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects　― A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER) Trial ―

Anthony Keech, Kazuma Oyama, Peter Sever et al. · Circulation Journal · 2021 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of evolocumab on acute arterial events across all vascular territories : results from the FOURIER trial

Kazuma Oyama, Robert P. Giugliano, Minao Tang et al. · European Heart Journal · 2021 · 47 citations

Medicine, Pharmacology, Pharmacotherapy +17

Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT

Kazuma Oyama, Robert P. Giugliano, Michael A. Blazing et al. · Journal of the American College of Cardiology · 2021 · 45 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

1–5 of 9